Prevalence of patent foramen ovale (PFO) and MRI-lesions in mild neurological decompression sickness (type B-DCS/AGE)

A E Koch1, H Kirsch, M Reuter

  • 1German Naval Medical Institute, Kiel-Kronshagen, Germany.

Abstract

Insights

Type B neurological decompression sickness (DCS/AGE) and patent foramen ovale (PFO) prevalence were similar in patients and controls. This suggests different underlying causes for Type A and Type B DCS/AGE, with Type B potentially not being embolic.

Area of Science:

  • Neurology
  • Diving Medicine
  • Cardiology

Background:

  • Neurological decompression sickness (DCS/AGE) presents in two types: Type A with severe central nervous system symptoms and Type B with milder symptoms.
  • Type A DCS/AGE is often linked to patent foramen ovale (PFO), suggesting an embolic origin.
  • The pathophysiology of Type B DCS/AGE may differ, potentially involving micro-embolic or non-embolic mechanisms.

Purpose of the Study:

  • To investigate the prevalence of PFO and brain lesions in patients with Type B DCS/AGE compared to matched controls.
  • To explore potential differences in pathophysiology between Type A and Type B DCS/AGE.

Main Methods:

  • 18 patients with Type B DCS/AGE underwent echocardiography and transcranial ultrasound with echo-contrast to assess PFO.
  • Cranial MRI was used to visualize Type A-brain lesions (ACFs) as potential sequelae of gas-embolic events.
  • Patients were compared with matched controls.

Main Results:

  • PFO prevalence was similar in Type B DCS/AGE patients (5/18) and controls (7/18), aligning with general population PFO rates (p = 0.725).
  • The number of MRI-identified brain lesions (ACFs) was comparable between Type B DCS/AGE cases (15 ACFs in 5 patients) and controls (37 ACFs in 8 divers).

Conclusions:

  • Findings suggest that indirect evidence of embolic brain injuries occurs with similar frequency in Type B DCS/AGE patients and controls.
  • This contrasts with findings in Type A DCS/AGE, supporting distinct pathophysiological mechanisms for Type A and Type B DCS/AGE.

Related Concept Videos

Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...